Access the full recording of our insightful webinar, “Rescheduled Realities,” and explore the transformative impact of cannabis rescheduling to Schedule III on the manufacturing sector.

In this fifth installment of NCIA’s #IndustryEssentials multi-part webinar series, our expert Cannabis Manufacturing Committee delves into the major shifts and implications following the rescheduling of cannabis. This session provides invaluable insights and practical guidance to help your business adapt and excel in the evolving landscape.

Learning Objectives:

• Future of Manufacturing Post-Rescheduling: Understand the anticipated changes and their impact on the industry.
• GMP and Regulatory Requirements: Navigate the updated Good Manufacturing Practices and regulatory standards.
• Focus on Extracts and Concentrates: Gain insights into the production and regulation of cannabis extracts and concentrates.
• Impact of Big Pharma: Explore how the pharmaceutical industry’s involvement might influence manufacturing.
• Best Practices for Non-Pharmaceutical Quality: Learn strategies to maintain high-quality standards in a non-pharmaceutical context.

Hear from Our Expert Panelists:

• James Granger – The Clear
• Annamaria Barajas – The Fischer Group
• Paula Winner Barnett – Green Zone Law
• Ben Larson – Vertosa
• Harrison Bard – Custom Cones USA
• Aaron Smith – NCIA
• Karla Rodriguez – EQO Insight

This session is essential for cannabis manufacturers looking to navigate the upcoming changes, ensure compliance, and maintain high-quality production standards. Join us to stay informed and prepared for the future of cannabis manufacturing.

Why Watch?
Gain critical knowledge and practical tools to adapt to regulatory changes, enhance your manufacturing practices, and remain competitive in the market.

Watch Now to equip yourself with the insights needed to thrive in the new cannabis manufacturing landscape!